Read article Otavio Benvanger.2012-03-24
PARTNER cohort B: Clinical events at 3 years follow-up in patients with
Background: Percutaneous aortic valve implantation (TAVI) is the treatment of choice for patients with severe aortic stenosis considered inoperable according to clinical outcomes at 12 months as reported in the PARTNER study, which demonstrated a reduction in mortality and an improvement in the quality of life for patients. However, the long term benefit of this...
PARTNER cohort A at three years, the benefit continues
The PARTNER Cohort A randomized 699 elderly patients, (mean age 84.1), with severe aortic stenosis for TAVI or conventional surgery in 26 centers. The group of patients who received TAVI was divided into two groups: trans-femoral procedure, (244 patients), or trans-apical procedure, (104 patients). After one year mortality was similar but stroke and transient ischemic...
TCT Session
Alan Wilson and Szeto Zajarias show that vascular complications of the trans-femoral path remain an important factor because of the high profile of the catheters used in TAVI and the appearance of smaller devices, as well as the experience of surgeons, will progressively reduce complication rates. Josep Rodes-Cabau commented about the negative impact a stroke...
COREVALVE EXTREME RISK: Promising results with CoreValve in very high-risk patients
Percutaneous aortic valve implantation ( TAVI ) recently demonstrated its superiority over medical treatment in patients with severe aortic stenosis and high surgical risk. Furthermore patients receiving TAVI showed a survival surgery equivalent to one year. This study included 471 patients with symptomatic severe aortic stenosis discarded of surgery due a very high risk. The...
SOLACI relaunches its SOLidario program in Colombia
The Latin American Society of Interventional Cardiology successfully relaunched its SOLidario program, practicing the implantation of an aortic valve catheter (TAVI) in the Instituto de Angiografía de Occidente at Cali. It was during the XXIV SOLACI Conference edition held on October 30 and 31 in Colombia. SOLACI understands the need to develop a social...
Aortic stenosis, patient guide
Aortic valve stenosis occurs when calcium deposits in the valve cause leaflets hardening. It is a degenerative process that gets worse as the person ages. As the disease develops, valve opening is narrowed, obstructing blood flow and forcing the heart to pump harder. Aortic valve replacement is the standard treatment for severe aortic stenosis. Without...
EuroPCR 2015.
Find the coverage of the Congress- May 19 – 22 at the Palais des Congrès in Paris, France The SOLACI@euroPCR Session “Registries and imaging in TAVI and PCI, A Latin American perspective” was held on Wednesday 20th, at 10:30 in Room 342 AB, under the euroPCR Congress 2015. // Read the program If you cannot view...
Educational Journal N° 100
EDITORIAL Dr. Matías Sztejfman ARTICULO DE REVISION Dr. Fernando Cura Implante Valvular Aórtico en pacientes de alto riesgo quirúrgico, evidencia y hacia donde nos dirigimos REVISION BIBLIOGRAFICA Dr. Yigal Piña Reyna Estudio CoreValve US Pivotal en Pacientes de alto riesgo quirúrgico CASO CLINICO Dres. Gabriel Maluenda, Mario Araya y Michael Howard TAVI con Sapien XT™...
Educational Journal N° 98
1. ESTUDIOS DE TECNOLOGIAS EN INTERVENCIONES CORONARIAS • RIBS IV – Presentador: Fernando Alfonso • ABSORB II – Presentador: Patrick Serruys 2. ESTUDIOS DE FARMACOLOGIA EN INTERVENCIONES CORONARIAS • ISAR-TRIPLE – Presentador: Nikolaus Sarafoff • SECURITY – Presentador: Antonio Colombo • BRIGHT – Presentador: Yalin Hang 3. ESTUDIOS EN IMÁGENES CORONARIAS • IVUS-CTO – Presentador:...